These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 23912588)
1. Pharmacogenetics and the development of personalized approaches for combination therapy in asthma. Miller SM; Ortega VE Curr Allergy Asthma Rep; 2013 Oct; 13(5):443-52. PubMed ID: 23912588 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. Ortega VE; Meyers DA J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795 [TBL] [Abstract][Full Text] [Related]
3. Asthma pharmacogenetics: responding to the call for a personalized approach. Ortega VE; Wechsler ME Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):399-409. PubMed ID: 23799335 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. Ortega VE Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of the beta 2-adrenergic receptor gene. Ortega VE; Hawkins GA; Peters SP; Bleecker ER Immunol Allergy Clin North Am; 2007 Nov; 27(4):665-84; vii. PubMed ID: 17996583 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Chung KF; Caramori G; Adcock IM Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399 [TBL] [Abstract][Full Text] [Related]
7. A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Giembycz MA; Kaur M; Leigh R; Newton R Br J Pharmacol; 2008 Mar; 153(6):1090-104. PubMed ID: 18071293 [TBL] [Abstract][Full Text] [Related]
8. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related]
10. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272 [TBL] [Abstract][Full Text] [Related]
11. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Barnes PJ Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317 [TBL] [Abstract][Full Text] [Related]
12. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
13. Combined Analysis of Asthma Safety Trials of Long-Acting β Busse WW; Bateman ED; Caplan AL; Kelly HW; O'Byrne PM; Rabe KF; Chinchilli VM N Engl J Med; 2018 Jun; 378(26):2497-2505. PubMed ID: 29949492 [TBL] [Abstract][Full Text] [Related]
14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [TBL] [Abstract][Full Text] [Related]
15. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
17. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
18. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Miller-Larsson A; Selroos O Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of asthma. Hall IP Chest; 2006 Dec; 130(6):1873-8. PubMed ID: 17167011 [TBL] [Abstract][Full Text] [Related]
20. Managing asthma in the 21st century: role of pharmacogenetics. Wechsler ME Pediatr Ann; 2006 Sep; 35(9):660-2, 664-9. PubMed ID: 16999299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]